KeyBank National Association’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.2M | Buy |
71,724
+8,045
| +13% | +$1.21M | 0.04% | 234 |
|
|
2026
Q1 | $9.73M | Buy |
63,679
+10,666
| +20% | +$1.63M | 0.04% | 238 |
|
|
2025
Q4 | $7.31M | Buy |
53,013
+2,488
| +5% | +$326K | 0.03% | 261 |
|
|
2025
Q3 | $6.48M | Buy |
50,525
+1,148
| +2% | +$140K | 0.02% | 271 |
|
|
2025
Q2 | $5.98M | Buy |
49,377
+5,742
| +13% | +$647K | 0.02% | 278 |
|
|
2025
Q1 | $4.86M | Buy |
43,635
+200
| +0.5% | +$21.3K | 0.02% | 286 |
|
|
2024
Q4 | $4.23M | Buy |
43,435
+315
| +0.7% | +$33.6K | 0.02% | 310 |
|
|
2024
Q3 | $4.96M | Buy |
43,120
+1,058
| +3% | +$120K | 0.02% | 295 |
|
|
2024
Q2 | $4.48M | Buy |
42,062
+1,161
| +3% | +$117K | 0.02% | 293 |
|
|
2024
Q1 | $3.96M | Sell |
40,901
-744
| -2% | -$76.3K | 0.02% | 308 |
|
|
2023
Q4 | $4.2M | Buy |
41,645
+3,643
| +10% | +$352K | 0.02% | 299 |
|
|
2023
Q3 | $3.87M | Buy |
38,002
+256
| +0.7% | +$26K | 0.02% | 292 |
|
|
2023
Q2 | $3.81M | Sell |
37,746
-3,682
| -9% | -$368K | 0.02% | 299 |
|
|
2023
Q1 | $3.81M | Sell |
41,428
-1,024
| -2% | -$89.4K | 0.02% | 300 |
|
|
2022
Q4 | $3.85M | Sell |
42,452
-1,226
| -3% | -$103K | 0.02% | 296 |
|
|
2022
Q3 | $3.32M | Buy |
43,678
+1,779
| +4% | +$147K | 0.02% | 298 |
|
|
2022
Q2 | $3.54M | Sell |
41,899
-2,103
| -5% | -$185K | 0.02% | 294 |
|
|
2022
Q1 | $3.86M | Sell |
44,002
-270
| -0.6% | -$23.4K | 0.02% | 294 |
|
|
2021
Q4 | $3.87M | Sell |
44,272
-840
| -2% | -$69.7K | 0.02% | 300 |
|
|
2021
Q3 | $3.69M | Buy |
45,112
+2,126
| +5% | +$191K | 0.02% | 299 |
|
|
2021
Q2 | $3.92M | Sell |
42,986
-339
| -0.8% | -$30.2K | 0.02% | 296 |
|
|
2021
Q1 | $3.7M | Sell |
43,325
-4,113
| -9% | -$369K | 0.02% | 295 |
|
|
2020
Q4 | $4.48M | Sell |
47,438
-4,156
| -8% | -$363K | 0.02% | 269 |
|
|
2020
Q3 | $4.49M | Sell |
51,594
-28
| -0.1% | -$2.43K | 0.02% | 261 |
|
|
2020
Q2 | $4.51M | Sell |
51,622
-4,179
| -7% | -$361K | 0.03% | 258 |
|
|
2020
Q1 | $4.6M | Sell |
55,801
-1,592
| -3% | -$142K | 0.03% | 244 |
|
|
2019
Q4 | $5.43M | Buy |
57,393
+1,105
| +2% | +$99.2K | 0.03% | 259 |
|
|
2019
Q3 | $4.89M | Sell |
56,288
-6,115
| -10% | -$549K | 0.03% | 264 |
|
|
2019
Q2 | $5.7M | Sell |
62,403
-8,885
| -12% | -$752K | 0.03% | 256 |
|
|
2019
Q1 | $6.14M | Sell |
71,288
-10,830
| -13% | -$869K | 0.04% | 243 |
|
|
2018
Q4 | $6.31M | Sell |
82,118
-1,092
| -1% | -$85K | 0.04% | 221 |
|
|
2018
Q3 | $6.42M | Buy |
83,210
+818
| +1% | +$60.5K | 0.04% | 234 |
|
|
2018
Q2 | $5.58M | Sell |
82,392
-3,440
| -4% | -$237K | 0.03% | 245 |
|
|
2018
Q1 | $6.22M | Sell |
85,832
-5,932
| -6% | -$452K | 0.04% | 230 |
|
|
2017
Q4 | $6.9M | Sell |
91,764
-2,193
| -2% | -$165K | 0.04% | 223 |
|
|
2017
Q3 | $7.23M | Sell |
93,957
-3,685
| -4% | -$278K | 0.04% | 223 |
|
|
2017
Q2 | $7.3M | Sell |
97,642
-529
| -0.5% | -$37.5K | 0.04% | 226 |
|
|
2017
Q1 | $6.53M | Sell |
98,171
-2,529
| -3% | -$169K | 0.04% | 229 |
|
|
2016
Q4 | $6.57M | Buy |
100,700
+10,454
| +12% | +$678K | 0.04% | 226 |
|
|
2016
Q3 | $6.38M | Sell |
90,246
-908
| -1% | -$66.2K | 0.04% | 224 |
|
|
2016
Q2 | $6.74M | Sell |
91,154
-5,650
| -6% | -$390K | 0.04% | 211 |
|
|
2016
Q1 | $6.28M | Sell |
96,804
-7,217
| -7% | -$491K | 0.04% | 214 |
|
|
2015
Q4 | $8.02M | Sell |
104,021
-6,531
| -6% | -$519K | 0.05% | 201 |
|
|
2015
Q3 | $9.11M | Sell |
110,552
-3,141
| -3% | -$280K | 0.06% | 188 |
|
|
2015
Q2 | $10M | Sell |
113,693
-4,487
| -4% | -$412K | 0.07% | 198 |
|
|
2015
Q1 | $10.4M | Sell |
118,180
-5,945
| -5% | -$527K | 0.07% | 193 |
|
|
2014
Q4 | $10.3M | Sell |
124,125
-3,437
| -3% | -$285K | 0.07% | 189 |
|
|
2014
Q3 | $10.8M | Sell |
127,562
-6,747
| -5% | -$546K | 0.07% | 183 |
|
|
2014
Q2 | $10.9M | Sell |
134,309
-21,489
| -14% | -$1.69M | 0.07% | 182 |
|
|
2014
Q1 | $11.9M | Sell |
155,798
-11,819
| -7% | -$861K | 0.09% | 175 |
|
|
2013
Q4 | $12.1M | Sell |
167,617
-25,673
| -13% | -$1.78M | 0.08% | 174 |
|
|
2013
Q3 | $13.3M | Sell |
193,290
-56,867
| -23% | -$3.76M | 0.09% | 168 |
|
|
2013
Q2 | $15.8M | Buy |
+250,157
| New | +$16.3M | 0.06% | 364 |
|
Other funds holding NVS
KeyBank National Association's NVS Position: Q2 2026 in Review
KeyBank National Association increased its Novartis (NVS) stake by 13% in Q2 2026, buying an estimated $1.21M and bringing the position to 71,724 shares worth $11.2M. The position accounts for 0.04% of the portfolio, ranked #234.
KeyBank National Association first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.8M in Q2 2013. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- KeyBank National Association held 71,724 shares of Novartis worth $11.2M as of Q2 2026.
- KeyBank National Association bought 8,045 Novartis shares in Q2 2026, an estimated $1.21M.
- Novartis made up 0.04% of KeyBank National Association's portfolio in Q2 2026, its #234 holding.
- KeyBank National Association first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- KeyBank National Association's Novartis position peaked at $15.8M in Q2 2013.
- 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.